Ignite Creation Date:
2024-07-17 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06464237
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-12
Brief Title:
Metacognitive Intervention in Youth With Oncological Disease - the Mio Study
Sponsor:
Insel Gruppe AG University Hospital Bern
Organization:
Insel Gruppe AG University Hospital Bern
Study Overview
Official Title:
Metacognitive Intervention in Youth With Oncological Disease - the Mio Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Mio
Brief Summary:
The aim of the Mio-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in adolescents with cancer Through the use of the Mio-App cognitive and physical development will be strengthened and metacognitive thinking and awareness will increase
The Mio-App for adolescence with cancer will include a combination of cognitive and physical training tasks and prospective as well as retrospective metacognitive questions In a randomized controlled trial the App will be analysed for its efficacy on metacognitive thinking and executive functions In particular the investigators are interested in factors that affect the efficacy of the training program such as compliance age sex or the presence of fatigue This study will give insight into the role of metacognition in cognitive and physical performance and will foster the development of adolescents with cancer in the long-term
The Mio-App for adolescence with cancer will include a combination of cognitive and physical training tasks and prospective as well as retrospective metacognitive questions In a randomized controlled trial the App will be analysed for its efficacy on metacognitive thinking and executive functions In particular the investigators are interested in factors that affect the efficacy of the training program such as compliance age sex or the presence of fatigue This study will give insight into the role of metacognition in cognitive and physical performance and will foster the development of adolescents with cancer in the long-term
Detailed Description:
In the Mio-Study the investigators are developing a training app at the interface between neuropsychology and sports science - the Mio-training The aim of the Mio-training is to strengthen the cognitive and motor development of adolescents after cancer in the long-term The App contains a combination of cognitive and physical training tasks and metacognitive questions to promote knowledge and awareness of ones own thinking In order to counteract the shortage of skilled workers and the increasing specialization of individual specialist areas solutions are needed that can be implemented without a lot of staff From todays perspective there are hardly any trainings for adolescents that show long-term effects on cognitive and motor development and can also be transferred to non-trained tasks in school and everyday life
The investigators are testing the effectiveness of the Mio-training in a randomized clinical trial RCT and expect a strengthening of metacognition and core cognitive functions ie executive functions The Mio-Study will provide information about the role of metacognition in cognitive and physical performance and ideally provide evidence for a novel interdisciplinary rehabilitation strategy for adolescents after cancer
The investigators are testing the effectiveness of the Mio-training in a randomized clinical trial RCT and expect a strengthening of metacognition and core cognitive functions ie executive functions The Mio-Study will provide information about the role of metacognition in cognitive and physical performance and ideally provide evidence for a novel interdisciplinary rehabilitation strategy for adolescents after cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None